Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases

Frontiers in Immunology

Immunology

Ying Zhu¹  Benqiao Wang¹  Ruixia Zhu¹  Yuehan Hao¹ 

[1] Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, China;

关键词: autoimmune diseases;    myasthenia gravis;    neuromyelitis optica;    autoimmune encephalitis;    multiple sclerosis;    inflammatory myopathy;   

DOI  :  10.3389/fimmu.2023.1223322

 received in 2023-05-16, accepted in 2023-08-23,  发布年份 2023

来源: Frontiers

【 摘 要 】

Multiple reports on the co-existence of autoimmune diseases and myasthenia gravis (MG) have raised considerable concern. Therefore, we reviewed autoimmune diseases in MG to explore their clinical presentations and determine whether the presence of autoimmune diseases affects the disease severity and treatment strategies for MG. We reviewed all the major immune-mediated coexisting autoimmune conditions associated with MG. PubMed, Embase and Web of Science were searched for relevant studies from their inception to January 2023. There is a higher frequency of concomitant autoimmune diseases in patients with MG than in the general population with a marked risk in women. Most autoimmune comorbidities are linked to AChR-MG; however, there are few reports of MuSK-MG. Thyroid disorders, systemic lupus erythematosus, and vitiligo are the most common system autoimmune diseases associated with MG. In addition, MG can coexist with neurological autoimmune diseases, such as neuromyelitis optica (NMO), inflammatory myopathy (IM), multiple sclerosis (MS), and autoimmune encephalitis (AE), with NMO being the most common. Autoimmune diseases appear to develop more often in early-onset MG (EOMG). MS coexists more commonly with EOMG, while IM coexists with LOMG. In addition, MG complicated by autoimmune diseases tends to have mild clinical manifestations, and the coexistence of autoimmune diseases does not influence the clinical course of MG. The clinical course of neurological autoimmune diseases is typically severe. Autoimmune diseases occur most often after MG or as a combined abnormality; therefore, timely thymectomy followed by immunotherapy could be effective. In addition, thymoma-associated AChR MG is associated with an increased risk of AE and IM, whereas NMO and MS are associated with thymic hyperplasia. The co-occurrence of MG and autoimmune diseases could be attributed to similar immunological mechanisms with different targets and common genetic factor predisposition. This review provides evidence of the association between MG and several comorbid autoimmune diseases.

【 授权许可】

Unknown   
Copyright © 2023 Zhu, Wang, Hao and Zhu